DIRS.INFO The most relevant business & tech news

Other analysts saw upside for Coinbase and DoorDash along with Meta Platforms, as the social network builds advertising market share. The firm initiated coverage of DoorDash stock with a buy rating and a $165 per share price target. The analyst reiterated his overweight rating on Tesla stock but lowered his price target slightly to $310 per share from $320. The firm reiterated a buy rating on Meta stock and raised its price target to $585 per share from $550 on Thursday. Meta stock has surged more than 43% in 2024.

Persons: Morgan Stanley, Pamela Kaufman, Kaufman, — Jesse Pound, Mark Zgutowicz, — Brian Evans, Oliver Wintermantel, Wintermantel, Brian Evans, Morgan Stanley's Adam Jonas, Morgan Stanley's, Adam Jonas, Tesla's, Jonas, Tesla, — Brian Evans TSLA, Oppenheimer, Coinbase, Owen Lau, Jefferies, Brent Thill, outgrow Amazon's, Meta, Thill, Erika Najarian, Najarian, BofA's Organizations: CNBC, Jefferies, Bank of America, UBS, Big Four, Meta, Hershey, ISI, Tesla Network, 2Q, Amazon, UBS downgrades Bank of America Locations: Big Four U.S, Hershey, cryptocurrency, Wednesday's, 2H24

☆ Majority of GLP-1 users are using it primarily for weight loss, says Morgan Stanley's Kaufman
▼ + stars: | 2024-02-23 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMajority of GLP-1 users are using it primarily for weight loss, says Morgan Stanley's KaufmanPamela Kaufman, Morgan Stanley, joins 'Money Movers' to discuss the company's GLP-1 growth survey, the companies who are winners in the face of GLP-1 growth, and much more.

Persons: Morgan Stanley's Kaufman Pamela Kaufman, Morgan Stanley

☆ Cocoa prices just hit a record high. Here's what's driving the gains and what it means for chocolate makers
▼ + stars: | 2024-02-17 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +7 min

If you think chocolate prices this Valentine's Day were more expensive than usual, it's not you. Year to date, futures contracts are up nearly 27%, with cocoa prices rising in six of the past seven weeks. Here's a breakdown of what's driving cocoa prices higher and how it impacts the investment case around two major chocolate stocks. Doshi thinks cocoa prices could sell off about 20%, taking them to around $4,500 to $4,800 per ton. In an interview with CNBC last week, he underscored the rising cocoa price outlook as the key driver for his lower rating.

Persons: Humza Hussain, El, Aakash Doshi, Doshi, Bernstein, Bruno Monteyne, … There's, Mondelez, Alexia Howard, Hershey, Michele Buck, Bernstein's Howard, Howard, I'd, Bryan Spillane, Morgan Stanley, Pamela Kaufman, Bank of America's Spillane Organizations: Asset Management, CNBC, Hershey, Citi, 2H, Street, Bank of America, Bank of, Cadbury Locations: Mondelez, El Niño, Ghana, Ivory, Nigeria, Europe

Shanker also raised his price target to $80 from $75, suggesting nearly 34% downside from Friday's close. — Spencer Kimball 8:16 a.m.: Loop Capital upgrades Corteva, touts growth acceleration in 2025 Corteva's stronger-than-expected 2024 full-year guidance will jumpstart a period of strong growth, according to Loop Capital. The firm upgraded the agricultural chemicals company to buy from hold and increased its price target to $65 from $57. Analyst Jay Sole upgraded Urban to neutral from sell and upped his 12-month price target by $20 to $41. Kaufman's $183 price target indicates roughly 6.3% downside for shares, which have fallen more than 18% over the past year.

Persons: headwinds, Morgan Stanley downgrades XPO, Morgan Stanley, Ravi, Shanker, — Michelle Fox, Julien Dumoulin, Smith, Duke's, — Spencer Kimball, Chris Kapsch, Kapsch, Brian Evans, Cassie Chan, they'll, Chan, —, Jay Sole, URBN, Sole, Urban's, — Pia Singh, Filippo Falorni, Falorni, Hershey, Stanley, Pamela Kaufman, Kaufman's, Hershey's, Kaufman, Graham Doyle, Doyle, Piper Sandler, David Amsellem, Amsellem, Amsellam, Christopher Horvers, Jan, Horvers, Fred Imbert, Dan Levy, Levy Organizations: CNBC, Barclays, Automotive, JPMorgan, Corp, Bank of America, Bank of America downgrades Duke Energy, Duke Energy, Duke, Wall, America, UBS, Urban Outfitters, Free People, Urban, Citi, PepsiCo, Citi Research, Pepsi, Hershey, GE Healthcare Technologies, UBS GE Healthcare Technologies, Pharmaceutical, Teva Pharmaceutical, Federal, Barclays downgrades Rivian, Rivian Automotive, North American EV Locations: Bank of America downgrades, GEHC, David Amsellem U.S

☆ These dividend-growing stocks are ripe for the picking in 2024, Morgan Stanley says
▼ + stars: | 2024-01-10 | by ( Darla Mercado | Cfp | ) www.cnbc.com time to read: +3 min

Dividend-growing stocks offer investors the ultimate of benefits: the prospect of rising income and stock price appreciation, Morgan Stanley found. Tech isn't usually associated with dividend income, but some semiconductor-related stocks made it to Morgan Stanley's list. Broadcom , an artificial intelligence beneficiary whose shares are up 88% in the past year, was also highlighted on Morgan Stanley's list of dividend ideas. Finally, Mondelez International , maker of Sour Patch Kids candy and Oreo cookies, made it to Morgan Stanley's list of dividend growers. Other names that made Morgan Stanley's list of companies that have raised their dividends include Accenture , Microsoft , Marathon Petroleum and D.R.

Persons: Morgan Stanley, Todd Castagno, Castagno, Morgan Stanley's, Lam, Atif Malik, Morgan, Goldman Sachs, Morgan Stanley's Pamela Kaufman, Mondelez Organizations: Federal Reserve, Equity, Tech, Lam Research, FactSet, Citi, Broadcom, Mondelez, Accenture, Microsoft, Marathon Petroleum Locations: U.S, Horton

☆ These stocks have the most at risk as patients on Ozempic eat less, according to Morgan Stanley
▼ + stars: | 2023-11-23 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +3 min

The use of weight-loss drugs such as Ozempic is poised to change consumer consumption patterns, but not every food-related company will get hit in the same way, according to Morgan Stanley. Fast food restaurants were especially vulnerable. "Shoppers with obesity spend more at large fast food brands and, on a relative basis, less at fast casual restaurants and casual diners," Morgan Stanley said. One stock that is closer to a risky pure play is McDonald's , which is second highest on the list, according to the Morgan Stanley research. Low cost retailers like Walmart and snack and beverage companies like Pepsico are also exposed, according to the Morgan Stanley research.

Persons: Morgan Stanley, Eli Lilly, Pamela Kaufman, Kaufman, Tim Hortons, Burger, Taco Bell, — CNBC's Michael Bloom Organizations: Novo Nordisk, Denmark's Novo Nordisk, Restaurant Brands, Yum Brands, Walmart, Pepsico Locations: U.S

☆ Morgan Stanley warns snack companies that weight loss drug study showed 'significant reduction in food consumption'
▼ + stars: | 2023-10-23 | by ( Alex Harring | ) www.cnbc.com time to read: +3 min

The use of Eli Lilly 's Mounjaro for weight loss can pull shoppers away from the snack aisle — though the transition will likely be gradual, according to Morgan Stanley. Kaufman noted a six-week study presented at ObesityWeek that showed users of Mounjaro cut calories and weight at a faster clip. The study also produced evidence that medication takers had a "significant reduction in food consumption," as well as fewer cravings for sweets and fast food fats. And while taking Mounjaro reduced food cravings overall, it had a particular impact on sweets, the study found. All four of the snack makers Kaufman said to watch have lost share value in 2023.

Persons: Eli Lilly, Morgan Stanley, Mounjaro, Pamela Kaufman, Kaufman, Hershey, Campbell, — CNBC's Michael Bloom Organizations: Drug Administration, Hershey, Brand Locations: Mondelez

☆ With Ozempic on the rise, food companies develop a plan
▼ + stars: | 2023-10-05 | by ( Danielle Wiener-Bronner | ) edition.cnn.com time to read: +5 min

“If they switch to different types of nutrients … we switch to different types of nutrients,” he said. Drugs like Ozempic could change how people eat, affecting food sellers. Big food companies are constantly evolving their products to adapt to consumer trends. And with wellness top of mind for many — not just people taking semaglutide drugs — companies have already tweaked their products in an effort to appeal to health-conscious consumers. “And then what is the churn rate?” To adapt to a possible shift, companies should be “planning for different scenarios,” she said.

Persons: Sean Connolly, “, ” Connolly, ” Conagra, Duncan Hines, Marie Callender’s, Jaap Arriens, ”, Bernstein, Alexia Howard, ” Howard, John Furner, Morgan Stanley, Pamela Kaufman, Ding Dongs, Mark Smucker, Jody Dushay, “ Dieticians, Deidre McPhillips Organizations: New, New York CNN, Wall Street, Healthy, PepsiCo, Coca, Walmart, Bloomberg, CNN, Companies, Brands, Harvard Medical School Locations: New York

☆ Morgan Stanley names its top dividend-paying stock picks
▼ + stars: | 2023-09-28 | by ( Darla Mercado | Cfp | ) www.cnbc.com time to read: +2 min

When picking dividend-paying stocks to stabilize your portfolio in tumultuous times, don't just go for higher yields — look for the growers, according to Morgan Stanley. Dividend-paying stocks have outperformed nondividend payers across all large-cap sectors going back to 2000, except for consumer discretionary, Morgan Stanley said. Energy Transfer , a company that operates in the natural gas pipeline industry, is rated overweight by Morgan Stanley analyst Robert Kad. Morgan Stanley also likes Mondelez International , the company behind Sour Patch Kids candy and Oreo cookies. Morgan Stanley anticipates banks will be able to grow their dividends about 5% in 2024.

Persons: Morgan Stanley, Morgan Stanley's, Robert Kad, Pamela Kaufman, Betsy Graseck, — CNBC's Michael Bloom Organizations: Mondelez, Financial, Regions Locations: outperformance, Birmingham , Alabama

☆ This nutritional snack company has a leg up on competitors, Morgan Stanley says in upgrade
▼ + stars: | 2023-09-18 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +1 min

Simply Good Foods ' diverse product offering could provide it an edge over market competitors, according to Morgan Stanley. The firm upgraded Simply Good Foods to an overweight rating from equal-weight on Monday, simultaneously bumping up its price target to $40 from $37. Shares of the food and beverage company have plunged almost 11% since the start of the year, creating an "attractive buying opportunity," analyst Pamela Kaufman wrote. The analyst also cited Simply Good Foods' above-average topline growth within the packaged food industry. "SMPL's solid topline growth outlook is an increasingly scarce asset in a group that is facing slowing topline growth and should support its valuation premium," she said.

Persons: Morgan Stanley, Pamela Kaufman, Kaufman, — CNBC's Michael Bloom Locations: Friday's

☆ Bet against America's love for junk food? Morgan Stanley sees tough times ahead for snack stocks like Hostess
▼ + stars: | 2023-09-11 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +3 min

Smucker 's plan to buy Twinkies -maker Hostess Brands is a risky move, if Morgan Stanley's latest research is correct. The firm revisited its August call that a new class of weight loss medications would hamper growth at some food and beverage companies . "Across our coverage, Numerator Insights data highlight that most center-store packaged food companies slightly over-index to consumers with obesity," Kaufman said. Hostess stock soared 19% on the news. Other food stocks with higher exposure to customers with obesity include Conagra , Kraft Heinz and Smucker, the report said, citing the Numerator data.

Persons: Smucker, Morgan Stanley's, Ding Dongs, Morgan Stanley, Pamela Kaufman, Atkins, Nordisk's Wegovy, Kaufman, Kraft Heinz, — CNBC's Michael Bloom Organizations: Hostess Brands, Centers for Disease Control, Nordisk's Locations: U.S, GLP

☆ A revolution in weight loss treatment may force a reckoning for food and beverage companies
▼ + stars: | 2023-08-13 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +10 min

One such prediction came Monday from Morgan Stanley analysts who forecasted a 1.3% drop in calorie consumption in the U.S. by 2035. The shift in behavior is notable because it will affect a sizeable demographic group that represents a disproportionate share of food consumption, the analysts said. In fact, some patients taking these medicines say they have to sometimes force themselves to eat due to a lack of appetite. These types of patterns were seen in consumer research Morgan Stanley conducted in June and July among 300 patients taking these medicines. Keurig Dr Pepper, with its coffee business accounting for about 30% of corporate sales, offers some diversification from at-risk beverage categories, Morgan Stanley said.

Persons: you've, Morgan Stanley, Pamela Kaufman, Read, Campbell, Mondelez, Eli Lilly's Mounjaro, Morgan Stanley's, Morgan, John David Rainey, We've, we're, Rainey, Dara Mohsenian, Eric Serotta, Dr Pepper Organizations: Hostess Brands, Hershey, Nordisk's Ozempic, Centers for Disease Control, Food and Drug Administration, Novo Nordisk, Industry, Lawmakers, Walmart Locations: U.S, Cava

Search resuls for: "Pamela Kaufman"

12 mentions found